Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria L Bae-Jump

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Gynecologic Oncology|July 3, 2015
Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signalingJianjun Han, Lu Zhang, Hui Guo, et al.
Photochemistry and Photobiology|March 11, 2025
Photodynamic priming overcomes platinum resistance from short-term exposure to select perfluoroalkyl substances in endometrial cancer cell linesBrittany P Rickard, Lauren A Sapienza-Lundie, Marta Overchuk, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|August 18, 2011
AMG 479, a novel IGF-1-R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathwaysAlbert Mendivil, Chunxiao Zhou, Leigh A Cantrell, et al.
Oncotarget|October 28, 2015
The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancerJessica E Stine, Hui Guo, Xiugui Sheng, et al.
Endocrine-Related Cancer|June 6, 2015
Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathwayLingqin Yuan, Xiugui Sheng, Adam K Willson, et al.
Journal of Cancer|December 8, 2015
Knockdown of hTERT and Treatment with BIBR1532 Inhibit Cell Proliferation and Invasion in Endometrial Cancer CellsWeimin Kong, Nenan Lv, Weiya Z Wysham, et al.
Journal of Hematology & Oncology|January 30, 2015
Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cellsXiaoyun Han, Xiugui Sheng, Hannah M Jones, et al.
Frontiers in Pharmacology|May 15, 2025
Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancerShuning Chen, Weimin Kong, Xiaochang Shen, et al.
Cancer|March 31, 2015
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancerJoan L Walker, C Bethan Powell, Lee-May Chen, et al.
Obstetrics and Gynecology|November 10, 2015
Association of Preoperative Thrombocytosis and Leukocytosis With Postoperative Morbidity and Mortality Among Patients With Ovarian CancerEmma L Barber, John F Boggess, Linda Van Le, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Gynecologic Oncology|July 3, 2015
Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signalingJianjun Han, Lu Zhang, Hui Guo, et al.
Photochemistry and Photobiology|March 11, 2025
Photodynamic priming overcomes platinum resistance from short-term exposure to select perfluoroalkyl substances in endometrial cancer cell linesBrittany P Rickard, Lauren A Sapienza-Lundie, Marta Overchuk, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|August 18, 2011
AMG 479, a novel IGF-1-R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathwaysAlbert Mendivil, Chunxiao Zhou, Leigh A Cantrell, et al.
Oncotarget|October 28, 2015
The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancerJessica E Stine, Hui Guo, Xiugui Sheng, et al.
Endocrine-Related Cancer|June 6, 2015
Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathwayLingqin Yuan, Xiugui Sheng, Adam K Willson, et al.
Journal of Cancer|December 8, 2015
Knockdown of hTERT and Treatment with BIBR1532 Inhibit Cell Proliferation and Invasion in Endometrial Cancer CellsWeimin Kong, Nenan Lv, Weiya Z Wysham, et al.
Journal of Hematology & Oncology|January 30, 2015
Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cellsXiaoyun Han, Xiugui Sheng, Hannah M Jones, et al.
Frontiers in Pharmacology|May 15, 2025
Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancerShuning Chen, Weimin Kong, Xiaochang Shen, et al.
Cancer|March 31, 2015
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancerJoan L Walker, C Bethan Powell, Lee-May Chen, et al.
Obstetrics and Gynecology|November 10, 2015
Association of Preoperative Thrombocytosis and Leukocytosis With Postoperative Morbidity and Mortality Among Patients With Ovarian CancerEmma L Barber, John F Boggess, Linda Van Le, et al.
Pageof 10